SFDA (Saudi Food & Drug Authority) adopted on 06 June 2018 , Good Manufacturing Practice for Blood Establishments. The purpose of this document is to provide […]

04 June 2018: FDA approves first biosimilar to Neulasta (pegfilgrastim) of Mylan GmbH. This porduct helps to reduce the risk of infection during cancer treatment . […]

Tunisia Hosts African Economic Forum on 24 and 25 April 2018